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Background and Objectives: This study aimed to explore the changes of gut bacteria in bladder cancer patients. 
Methods and Study Design: Newly diagnosed bladder cancer patients were recruited. All participants complet-
ed a questionnaire about personal behavior and diet. Pyrosequencing of the total genomic DNA extracted from 
human feces was carried out by Illumina HiSeq 2000. The copy number of target DNA for bacteria was deter-
mined by real-time quantitative PCR assay. Fecal short chain fatty acids contents were measured by gas chroma-
tography (GC) analysis. The concentrations of lipopolysaccharide and D-lactic acid in serum were determined by 
enzyme-linked immunosorbent assay kits. Results: Fruit intake was significantly lower than in healthy controls. 
The numbers of Clostridium cluster XI and Prevotella in bladder cancer patients decreased. The numbers of do-
main bacteria and Prevotella were significantly and positively associated with fruit intake (r=0.002, p<0.05 for 
domain bacteria; r=0.004, p<0.05 for Prevotella). The concentration of butyric acid decreased significantly in 
bladder cancer patients, and the quantities of fecal butyric acid were significantly and positively associated with 
fruit intake (r=0.610, p<0.01). The concentrations of lipopolysaccharide and D-lactic acid, two sensitive markers 
of gut permeability, were greater in bladder cancer patients. Conclusions: Dysbiosis of gut microbiota, decreased 
butyric acid concentrations and impaired intestinal structural integrity were found in bladder cancer patients, 
which might be associated with inadequate fruit intake. 
 





Urothelial bladder cancer (BC) generally originates from 
urothelium. The overall incidence of bladder cancer was 
5.71/105 in 2014 in China, ranking the sixth in male can-
cers.1 Transitional-cell carcinoma which accounts for 
over 90% of bladder cancer represents the most frequent 
histological type.2 Approximately 75% of the newly di-
agnosed patients are non-muscle-invasive bladder cancer 
(Ta or T1 of Tumor, Node, Metastasis (TNM) stage), and 
25% of the patients are muscle-invasive or metastatic 
diseases belonging to T2-T4 of TNM stage with bad 
prognosis.3 Besides cigarette smoking and occupational 
exposure to carcinogen,4 dietary factors, such as low con-
sumption of fruit and vegetable as well as high consump-
tion of processed meat are positively associated with BC 
risk,2,5 whereas its underlying mechanisms remain un-
known. 
Recently, some studies explored the composition of 
urinary bacterial communities in urinary tract. A small 
pilot study revealed an enrichment of Streptococcus in 
urine samples from BC patients (n=8).6 One possible 
mechanism is that microbiota produces proteases and then  
 
 
contacts with epithelium. These enzymes function as ex-
tracellular virulence factors in tissue degradation, evasion 
and destruction of host physical barriers. Bacterial eva-
sion generates inflammation and oxygen radicals that 
drive cancer and cancer recurrence.7  
Almost 99% of the microbial mass is located within the 
intestinal tract, and the microbiota and its host have co-
evolved into a complex ‘super-organism’.8 Moreover, gut 
microbiota exerts not only local but also long-distance 
effects on the host. To communicate with distant organs, 
gut microbial signals should be firstly transmitted across 
the intestinal epithelium.9 Failure of the intestinal barrier 
will cause the leakage of undesirable solutes, pathogenic 
microorganisms and toxins, which subsequently leads to  
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inflammation and immune activation.10 It has been sug-
gested that targeting inflammatory cytokines may be an 
effective therapeutic strategy for bladder cancer since for 
their important role in cancer formation and progres-
sion.11 
The human colonic microbiota produces an enormous 
quantity of molecules that impact on the gut homeosta-
sis.12 Short-chain fatty acids (SCFAs), such as acetate, 
propionate and butyrate, are synthesized from dietary 
carbohydrates by bacterial fermentation in large intes-
tine.13 Most SCFAs are locally produced in large intestine 
by specific bacterial species. Butyrate is mainly produced 
by Firmicutes, whereas acetate is dominated by most an-
aerobes.14 Approximately 80-90% of SCFAs are absorbed 
from the colonic lumen and partly utilized by colonic 
epithelial cells, and the rest are transferred to circulation 
or excreted in feces.14 Therefore, protective effects by 
SCFAs are not only presented in intestinal mucosa but 
also extended to other compartments of the body. SCFAs 
might play an essential role in prevention pathological 
conditions such as inflammatory bowel disease and can-
cer for its anti-neoplastic, anti-inflammatory and immune 
modulatory properties.15 Moreover, butyric acid showed 
the direct inhibitory effect on bladder cancer cell by in-
hibiting cell growth and inducing apoptosis in vitro.16 
Although epidemiological evidence implied the intake 
of fruit and vegetable was negatively associated with 
bladder cancer, the underlying mechanism remains un-
clear. Here, we aim to profile the characteristics of gut 
microbiota in bladder cancer, which will be helpful to 
uncover the diet-associated mechanism of bladder cancer. 
 
METHODS 
Patients and stool sample collection 
All participants were informed about the study purpose 
during the admission interview, and voluntarily signed 
consent forms prior to enrolling in the study. All proce-
dures in this study were compliant with the Declaration of 
Helsinki, and the study protocol was approved by the 
Ethics Committee of the First Affiliated Hospital of Har-
bin Medical University. This trial was registered at 
www.chictr.org.cn as ChiCTR-OOC-16007937. The pri-
vacy rights of human subjects were observed.  
BC patients were recruited for this study at the First 
Affiliated Hospital of Harbin Medical University between 
October 1, 2014 and January 30, 2015. Healthy controls 
(HCs) were recruited from patients who visited the First 
Affiliated Hospital of Harbin Medical University for 
physical examination. All of the BC patients and HCs 
were local residents, and of Han ancestry. None of the 
patients were undergoing radiotherapy, chemotherapy or 
other medical interventions. The exclusion criteria were 
as follows: 1) a history of taking antibiotics, aspirin, other 
non-steroidal anti-inflammatory drugs or probiotics with-
in the previous 6 months before enrollment; 2) a vegetari-
an diet; and 3) a history of any other cancer or inflamma-
tory disease of the intestine.17 According to the criteria, of 
the 74 subjects enrolled this study (40 for BC groups, 34 
for HC group), a total of 26 newly diagnosed patients 
with histologically and 16 HCs were qualified. 
Waxed tissue paper (Epitope Diagnostics, CA, USA) 
was used by participants, which was laid down on the 
water in the toilet bowl prior to defecation to avoid con-
tamination. All of the fresh stool samples were collected 
into sterilized and portable plastic containers and then 
were placed on ice and transported to the laboratory im-
mediately. Aliquots (200 mg/aliquot) were stored at -
80°C until analysis. 
 
Assessment of personal behavior and diet questionnaire 
Data on the subjects’ demographics, lifestyle factors and 
dietary information were collected from questionnaires by 
2 qualified clinical doctors. All the participants completed 
a questionnaire that was designed to provide information 
on health-related issues, including dietary information, 
smoking status, drinking status, and medical history.17 All 
of the participants were asked to recall the types and fre-
quency of foods eaten in the past three months. The ques-
tionnaires included 69 kinds of food and drinks. Accord-
ing the criteria mentioned by Chen et al, foods were 
grouped into three categories: fruits, vegetables and 
grains.17 Individual food intake was computed from the 
reported consumption frequency of each specified unit of 
food based on data from the Chinese Society of Nutrition 
regarding the nutrient content in the specified food types. 
According to the standard for evaluation developed by 
Chen et al., scores were assigned for smoking status, dai-
ly alcohol intake, food intake (vegetables, grains and 
fruits) and frequency of weekly vigorous exercise.17 
 
DNA extraction and 16S rRNA gene sequencing analy-
sis 
Total genomic DNA was extracted from fecal samples 
(human and mice, separately) aseptically using the QI-
Aamp DNA Stool Mini Kit (Qiagen, CA). Pyrosequenc-
ing of the total genomic DNA extracted from human fe-
ces was carried out by using an Illumina HiSeq 2000 by 
Sangon Biotech Co. Ltd. (Shanghai, China). The se-
quences were grouped into unique operational taxonomic 
units (OTUs) using 97% identity thresholds. The richness, 
Shannon index and Simpson rarefaction plot were calcu-
lated to compare the microbial diversity and richness 
among the HCs and four subgroups of BC patients 
(nTa=4, nT1=12, nT2=7, nT3=3). A Venn diagram with 
shared OTUs was shown to depict the similarities and 
differences among the five groups. UniFrac principal co-
ordinate analysis (PCoA) analysis was applied to compare 
the bacterial communities of the different groups based 
on phylogenetic information. The heatmap figure was 
generated using the R-package gplots.18 
 
RNA extraction, cDNA synthesis and real-time quantita-
tive PCR assay 
RNA was extracted with TRIzol Reagent (Life Technolo-
gies), and cDNA was synthesized from total RNA using 
the gDNA Removal and cDNA Synthesis Supermix Kit 
(TransGen Biotech, Beijing, China). The copy number of 
target DNA for bacteria was determined by comparison 
with serially diluted standards of plasmid DNA (102 to 
107 copies) containing the respective amplicon for each 
set of primers and was run on the same plate under the 
same conditions.19 Bacteria were quantified as log10 bac-
teria per gram of stool.20 All primers used for real-time 
qPCR were listed in Table 1. 
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GC analysis of SCFA content in fecal samples 
Fecal samples (2 g) were homogenized with 10 mL of 
deionized water for 10 min and centrifuged at 13200 g for 
20 min at 4°C. The supernatant was immediately filtered 
through a 0.45 μm microfiber filter, and then 1 mL of 
supernatant was placed in a 1.5 mL GC vial with 100 µL 
of formic acid. Six SCFAs (≥99%, analytical standard, 
Sigma) (acetic acid, propionic acid, butyric acid, iso-
butyric acid, valeric acid and iso-valeric acid) were serial-
ly diluted to make standard curves separately. Then, the 
concentrations of six SCFAs were quantified by GC (Ag-
ilent 7890; Agilent Technologies, USA) equipped with a 
flame ionization detector (FID) according to the stand-
ards.21 Total SCFAs concentrations were calculated as the 
sum of six SCFAs (acetic acid, propionic acid, butyric 
acid, iso-butyric acid, valeric acid and iso-valeric acid). 
 
Determination of lipopolysaccharide (LPS) and D-lactic 
acid levels in serum 
For patients and healthy controls, venous blood was col-
lected. All the serum was centrifuged after clotting at 
room temperature. Aliquots of each serum sample were 
stored at -80℃ until analyzed. The concentrations of LPS 
and D-lactic acid were determined by enzyme-linked im-
munosorbent assay (ELISA) kits from Jiancheng Bioen-
gineering Institute (Nanjing, P. R China) according to the 
manufacturer’s instructions. The concentrations were 
spectrophotometrically quantified by measuring the ab-
sorbance at 450 nm. The results were expressed as 
μmol/mL for D-lactic acid and ng/mL for LPS. 
 
Statistical analysis 
The statistical analysis was performed using SPSS ver- 
sion 19.0 (SPSS Inc., Chicago, IL, USA). Continuous 
data were reported as the mean ± SD. One-way analysis 
of variance (ANOVA) was used to compare the differ-
ences. Categorical variables were compared using chi-
squared and Fisher’s exact tests. Correlation was subject-
ed to Pearson correlation analysis. A two-sided p value 
<0.05 was considered to indicate statistical significance. 
 
RESULTS 
Demographics and lifestyle-related factor analysis 
Diet has an influence on the gut microbiota 
composition.22 Moreover, diverse studies have 
demonstrated that cigarette smoking and dietary factors 
such as the decreased intake of fruit and vegetable were 
associated with an increased risk of BC.23 Thus, we 
evaluated health-related issues including food intake 
(vegetables, grains and fruits), frequency of weekly 
vigorous exercise, smoking and drinking status for all 
individuals. No significant differences were observed in 
age, sex, body mass index or percent of overweight 
between two groups (Table 2). In addition, the ratios 
(scores from 0 to 4) of smoking, drinking alcohol and 
weekly vigorous exercise in the two groups showed no 
difference (Table 3). Data from food questionnaires 
indicated that fruit intake in the BC group was markedly 
reduced in contrast with that in the HC group (the ratio 
for fruit scores from 0 to 3, 14:8:4:0 for the BC group 
versus 2:9:5:0 for the HC group, p=0.026) (Table 3). 
 
Changes in fecal microbial communities and microbial 
components in BC patients 
Firstly, 83815 sequences were obtained for high 
throughput sequencing. Then, a total of 70702 optimized 
Table 1. Primers used for real-time qPCR 
 
Target group  Primer Sequence Reference 
Clostridium cluster I  F 5’-TACCHRAGGAGGAAGCCAC-3’ 20 
R 5’-GTTCTTCCTAATCTCTACGCAT-3’ 
 
Faecalibacteriumprausnitzii F 5’-GATGGCCTCGCGTCCGATTAG-3’ 20 
R 5’-CCGAAGACCTTCTTCCTCC-3’ 
 
Clostridium cluster XI  F 5’-ACGCTACTTGAGGAGGA-3’ 20 
R 5’-GAGCCGTAGCCTTTCACT-3’ 
 
Lactobacillus group F 5’-AGCAGTAGGGAATCTTCCA-3’ 20 
R 5’-ATTYCACCGCTACACATG-3’ 
 
Clostridium leptum subgroup  F 5’-TTACTGGGTGTAAAGGG-3’ 36 
R 5’-TAGAGTGCTCTTGCGTA-3’ 
 
Clostridium coccoides group F 5’- AAATGACGGTACCTGACTAA-3’ 37 
R 5’-CTTTGAGTTTCATTCTTGCGAA-3’ 
 
Bacteroides-Prevotella group F 5’-GAAGGTCCCCCACATTG-3’ 20 
R 5’-CAATCGGAGTTCTTCGTG-3’ 
 
Bacteroides fragilis group F 5’-AYAGCCTTTCGAAAGRAAGAT-3’ 38 
R 5’-CCAGTATCAACTGCAATTTTA-3’ 
 
Bifidobacterium genus  F 5’-GGGTGGTAATGCCGGATG-3’ 37 
R 5’-TAAGCCATGGACTTTCACACC-3’ 
 
Atopobium cluster F 5’-GGGTTGAGAGACCGACC-3’ 38 
R 5’-CGGRGCTTCTTCTGCAGG-3’ 
 
Enterobacteriaceae F 5’-CATTGACGTTACCCGCAGAAGAAGC-3’ 20 
R 5’-CTCTACGAGACTCAAGCTTGC-3’ 
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sequences were used for downstream analysis (on 
average, 14140±1855 reads per sample) and were 
clustered into 3233 OTUs. The results of richness 
diversities, Shannon index, and Simpson rarefaction plot 
indicated that bacterial diversities in the BC groups were 
reduced (data not shown).  
On account of the decreased bacterial diversities in BC 
patients, the detailed distributions of fecal microbial 
communities at the phylum level were studied (Figure 
1A). The main differences between the HC and BC 
groups were attributed to Bacteroidetes and Firmicutes, 
which accounted for up to 85% of the overall on average. 
The abundance of bacteria at the class level in all groups 
is presented in Figure 1B. The results of PCoA (Figure 
1C) indicate that the fecal microbial communities of BC 
patients and HCs are separate as P1, P2 and P3 (43.3%, 
33.5% and 17.4% of the explained variance, 
respectively). 
Table 2. Clinicopathological parameters between patients and healthy controls 
 
Parameters HC (n=16) 
BC 
(n=26) p value 
Ages (years)/ range† 58.5±10.6 62.2±9.80 0.162 
Sex [% (n)]   0.095 
 Male 43.8 (7) 69.2(18)  
 Female 56.3 (9) 30.8 (8)  
BMI (kg/m2) † 23.8±3.07 24.3±3.30 0.606 
Overweight [% (n)] ‡ 37.5 (6) 34.6 (9) 0.852 
Tumor stage     
 Ta 4 
 
 
 T1 12 
 
 
 T2 7 
 
 




HC: healthy controls; BC: bladder cancer patients.  
†Data were expressed as the mean±SD.  
‡Categorical variables were compared by a chi-square test or Fisher’s exact test. 
 
 
Table 3. Personal behavior-related characteristics between patients and healthy controls 
 
Parameters HC (n=16) 
BC 
(n=26) p value 
Smoking [%(n)]†,‡                                          0.960 
 0 6.25 (1) 7.69 (2)  
 1 18.8 (3) 26.9 (7)  
 2 0.00 (0) 3.85 (1)  
 3 6.25 (1) 3.85 (1)  
 4 68.8(11) 57.7 (15)  
Weekly vigorous exercise [%(n)]†,‡ 
  
0.163 
 1 93.8 (15) 76.9 (20)  
 2 6.25 (1) 3.85 (1)  
 3 0.00 (0) 19.2 (5)  
Alcohol [% (n)] †,‡ 
  
0.206 
 0 6.25 (1) 15.4 (4)  
 1 43.8(7) 15.4 (4)  
 2 0.00 (0) 3.85 (1)  
 3 0.00 (0) 0.00 (0)  
Vegetables [% (n)] †,‡ 
 
0.381 
 0 0.00 (0) 0.00 (0)  
 1 93.8 (15) 100 (26)  
 2 6.25 (1) 0.00 (0)  
 3 0.00 (0) 0.00 (0)  
Grains [% (n)] †,‡                                          0.106 
 0 0.00 (0) 0.00 (0)  
 1 68.8 (11) 50.0 (13)  
 2 25.0 (4) 50.0 (13)  
 3 6.25 (1) 0.00 (0)  
Fruits [% (n)] †,‡  
 
0.026 
 0 12.5 (2) 53.9 (14)  
 1 56.3(9) 30.8 (8)  
 2 31.3 (5) 15.4 (4)  
 3 0.00 (0) 0.00 (0)  
 
HC: healthy controls; BC: bladder cancer patients. 
†Categorical variables were compared by a chi-square test or Fisher’s exact test. 
‡Scores for personal behavior information were according to Chen et al.17 
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Twelve dominant bacterial groups, mainly belonging to 
the phyla Firmicutes, Bacteroidetes, Actinobacteria and 
Proteobacteria, were analyzed by real-time qPCR (Table 
4). The numbers of domain Bacteria, Clostridium cluster 
XI and Prevotella in BC patients were significantly lower 
than those in HC group (p<0.05). Other microorganism 
such as Clostridium cluster I and Faecalibacterium 
 
Figure 1. The composition of the fecal microbiota in the BC patients and healthy controls. (A) The compositional gut microbiota profiles 
are shown at the phylum level in the healthy control group and four subgroups of BC patients (each color represents one bacterial phy-
lum). (B) The heatmap of specimens shows the relative abundance of main bacteria at the class level. (C) PCoA-estimated gut microbiota 
in the healthy control group and four subgroups of BC patients. HC: healthy controls; BC: bladder cancer patients  
 
 
Table 4. Qualification of fecal bacteria from patients and healthy controls by real-time qPCR 
 
Bacteria group  HC BC p value 
Domain Bacteria 8.01±0.64 7.47±0.25 0.006 
Phylum: Firmicutes 
   
 Clostridium cluster I 4.46±0.77 3.96±1.46 0.191 
 Faecalibacterium prausnitzii 7.41±0.75 7.49±0.97 0.775 
 Clostridium cluster XI 4.97±0.67 4.40±0.85 0.031 
 Lactobacillus group 4.98±0.90 4.83±0.53 0.531 
 Clostridium leptum subgroup 7.41±1.17 6.82±1.10 0.122 
 Clostridium coccoides group 5.31±0.89 5.56±0.95 0.446 
Phylum: Bacteroidetes 
   
 Bacteroides-Prevotella group 7.54±1.21 6.52±0.90 0.004 
 Bacteroides fragilis group 5.94±0.81 6.06±1.17 0.732 
Phylum: Actinobacteria 
   
 Bifidobacterium genus 2.80±1.03 3.37±1.12 0.100 
 Atopobium cluster 5.88±0.71 5.47±0.77 0.128 
Phylum: Proteobacteria 
   
 
Enterobacteriaceae 3.04±1.01 3.27±1.03 0.580 
 
HC: healthy controls; BC: bladder cancer patients  
                                                           Potential role of gut microbiota in bladder cancer                                                  xxx                                                             
prausnitzii were not significantly different between the 
two groups.  
Correlation analysis was used in patients and healthy 
controls to analyze the relationship between fruit 
consumption and bacteria amounts; the numbers of 
domain bacteria and Prevotella were positively and 
significantly correlated with the fruit consumption 
(Figure 2A&B). 
 
Decreased concentrations of SCFAs in BC patients 
The microbiota is enriched in genes relevant for dietary 
nutrient absorption.24 The quantities of SCFAs, the 
fermented metabolites of undigestible carbohydrates in 
the colon and cecum were measured. As shown in Figure 
3A, the contents of butyric acid in the BC group 
(69.4±45.1 μmol/g) were lower than those in the HC 
group (125±39.7 μmol/g) (p<0.05). To explore whether a 
lower fruit intake is associated with a decreased 
concentration of butyrate, correlation analysis was 
performed for patients and healthy controls. According to 
the r value, butyric acid concentration is positively and 
significantly correlated with fruit consumption (Figure 
3B). 
 
Excessive LPS and D-lactic acid in BC patients 
SCFAs, especially butyrate, act as a key energy source for 
intestinal epithelial cells (IECs) and impact on mucosal 
integrity by stimulating the growth of IECs.25 LPS and D-
lactic acid, known as two sensitive markers of gut 
permeability, can penetrate across the intestinal 
epithelium when the intestinal barrier is impaired.26,27 As 
shown in Figure 4, the concentrations of LPS and D-lactic 
acid in the BC group were both significantly higher in 
contrast with those in the HC group (7.89±2.85 ng/mL 
versus 3.19±1.00 ng/mL for LPS, 49.3±47.0 μmol/mL 







Figure 2. Relationship of bacteria amounts (log10/g) and fruit intake (g/d) in the BC patients and healthy individuals. Pearson’s correlation 
analysis was performed. (A) For the relationship between domain bacteria and fruit intake, r=0.002, and p<0.05. (B) For the relationship 




Figure 3. SCFAs concentrations in BC patients. (A) GC analysis of SCFAs concentrations in fecal samples from BC patients and HCs. (B) 
Relationship of butyric acid (μmol/g) and fruit intake (g/d) in the BC patients and healthy individuals. Pearson’s correlation analysis was  
r=0.610, with p<0.01. HC: healthy controls; BC: bladder cancer patients  
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DISCUSSION 
BC is a most costly cancer to treat, and there is a pressing 
need for new and potential therapeutic targets and path-
ways. Our previous work has demonstrated that abnormal 
fecal microbiota composition and impaired gut epithelial 
barrier are to be found in N-butyl-N-(4-hydroxybutyl)-
nitrosamine induced bladder cancer in mice.28 Here we 
have explored the gut microbiota composition in BC pa-
tients as a possible therapeutic consideration .  
In the present study, the numbers of Clostridium cluster 
XI and Prevotella were both significantly lower in BC 
patients than those in the HC group. Clostridium cluster 
XI is known to be  a SCFA-producing microorganism.29 
Prevotella is positively associated with dietary fiber con-
sumption and induces the fermentation of complex poly-
saccharides.30 A high level of Prevotella is found in 
healthy people, but not patients with colorectal or breast 
cancer, consistent with our findings.31 Meanwhile SCFAs 
(especially butyric acid), were decreased in  patients. Bu-
tyrate is essential for growth and proliferation of IECs, 
and maintains homeostasis of the intestinal mucosal bar-
rier.25 Butyrate, also known as a histone deacetylase in-
hibitor, significantly inhibits cell growth and inducts 
apoptosis in bladder cancer cell lines in vitro.25 Exposure 
to butyrate can sensitize bladder cancer cells to chemo-
therapeutic  agents in vitro.32 The decreased levels of bu-
tyrate in BC patients might delay the proliferation and 
development of IECs and also decrease its direct anti-
cancer effect on bladder cancer.  
 We have shown that the concentrations of LPS and D-
lactic acid, were both increased in patients, indicating a 
defect in gut intestinal integrity. Due to poor intestinal 
integrity, LPS entering the blood will stimulate the related 
immune cells or inflammatory cells to secrete inflamma-
tory cytokines, which in turns aggravates or even initiates 
carcinogenesis. Our previous studies indicate that the 
concentration of IL-6 in serum is elevated in mice with 
N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced bladder 
cancer accompanied by breakage of intestinal epithelium 
and the presence of inflammatory lesions in colon and 
cecum.28 
The present report shows that fruit consumption is pos-
itively associated with the numbers of domain bacteria 
and Prevotella, and amount of butyrate. Thus, inadequate 
fruit consumption might partly alter gut microbiota and 
SCFAs in BC patients. Dietary factors and dietary pat-
terns play a critical role in modulation of gut microbio-
ta.22 BC patients consumed less than 20 g fruit per day, 
which is well below recommendations (200 g/day).33 Pos-
sibly and consequently, the richness and composition of 
the intestinal flora, and also SCFAs were altered. The 
average fruit intake among Chinese is lower than the rec-
ommended intakes.34 The Chinese Nutrition Society in 
2012 showed the average intake of dietary fiber to be 
around 13 g, below the recommended 25 g. Inadequate 
dietary fiber, probably as a food marker of a wider range 
of food factors, is associated with lower overall mortality 
and cancer prevalence.35 Gut microbiota may serve as a 
bridge between dietary factors and cancer. Future re-
search can pursue this possibility in more detail.   
In summary, we have identified a gut microbiota-
associated mechanism for bladder cancer (Figure 5). 
However, our study is of a relatively small number of 
cases in all stages reflecting the low incidence of BC so 
that larger sample sizes will be required for the required 
confidence in these findings. 
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